• China SXT Pharmaceuticals will implement a 1-for-100 consolidation of Class A ordinary shares effective October 26, 2026.
• Post-consolidation trading is expected to begin at the market open that day on Nasdaq under the unchanged symbol SXTC.
• Outstanding Class A ordinary shares will fall from 68,677,498 to approximately 686,775; the two Class B ordinary shares remain unchanged.
• Fractional shares will be rounded up to the next whole share.
• Outstanding stock options, warrants and other rights to purchase Class A ordinary shares will be adjusted proportionately.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China SXT Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN78785) on October 22, 2026, and is solely responsible for the information contained therein.